Archive for category: News

Primordial Genetics has launched FOMO-21, its first bacterial protein expression product enabling soluble expression of insoluble proteins in E. coli....

To enable expansion of its staff and operations, and accommodate recent and anticipated R&D collaborations and industrial partnerships, Primordial...

This week, Primordial Genetics signed a Letter of Intent with a San Diego-based pharmaceutical company (‘Company A’), for a...

Primordial Genetics is pleased to announce that the United States Patent and Trademark Office has issued a Notice of...

Richard Schneeberger, PhD, MBA has joined Primordial Genetics Inc as acting Director of Business Development. Richard Schneeberger, PhD, MBA...

Alan Greener, PhD, has joined Primordial Genetics Inc. as Vice President of R&D. Alan has extensive experience developing advanced...

Primordial Genetics today announced the first closing of its Series A-2 financing round, including a group of 5 private...